ReviewHealth care science2026
Electronic Devices and Digital Therapeutics in Neuromuscular Diseases: Narrative Review on Current Applications in Patients' Management and Pharmacovigilance.
Review in Health care science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Digital health technologies have revolutionized the management of neuromuscular diseases (NMDs), offering novel opportunities for disease monitoring, rehabilitation, telemedicine, pharmacological research, and pharmacovigilance. This narrative review aims to provide an integrated overview of the current applications of digital health technologies in NMDs, highlighting their role in diagnosis, disease monitoring, rehabilitation, telemedicine, pharmacological research, and pharmacovigilance. Relevant articles were identified by interrogating PubMed using combinations of keywords including "neuromuscular diseases," "digital health," "digital therapeutics," "telemedicine," "wearable devices," "remote monitoring," "telerehabilitation," and "pharmacovigilance." This review describes how wearable devices, digital biomarkers, telemedicine platforms, and digital therapeutics can facilitate continuous and real-time monitoring of clinically relevant parameters, including muscle strength, mobility, physical activity, and disease progression. In addition, digital technologies support remote patient management, rehabilitation programs, early detection of clinical changes, and the development of personalized therapeutic interventions. Emerging evidence also suggests that digital health tools may improve the design and conduct of clinical trials, enhance the collection and analysis of real-world data and patient-reported outcomes, and contribute to more effective pharmacovigilance strategies. Despite challenges on data privacy, digital literacy, integration into healthcare system and the need for large-scale or long-term clinical trials, the integration of digital therapeutics, digital biomarkers, and pharmacovigilance frameworks represents a promising and still underexplored area of research that may substantially contribute to the development of precision medicine approaches in NMDs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.